The analysis included 2,723 individuals with a molecular genetic diagnosis of LS, carrying pathogenic or likely pathogenic variants in MLH1, MSH2, MSH6, PMS2 or EPCAM (see Table 1A for LS individual demographics). This evidence concerns the gene PMS2 and Leigh syndrome.